Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 贝达药业股份有限公司证券投资管理制度（2026年1月） | 2026-02-01 | Chinese | |
| 关于修订、制定公司部分治理制度的公告 | 2026-02-01 | Chinese | |
| 贝达药业股份有限公司融资管理制度（2026年1月） | 2026-02-01 | Chinese | |
| 贝达药业股份有限公司董事会专门委员会工作细则（2026年1月） | 2026-02-01 | Chinese | |
| 贝达药业股份有限公司章程（草案）（2026年1月） | 2026-02-01 | Chinese | |
| 贝达药业股份有限公司章程（草案）修订对照表 | 2026-02-01 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 37811798 | 贝达药业股份有限公司证券投资管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811795 | 关于修订、制定公司部分治理制度的公告 | 2026-02-01 | Chinese | ||
| 37811791 | 贝达药业股份有限公司融资管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811785 | 贝达药业股份有限公司董事会专门委员会工作细则（2026年1月） | 2026-02-01 | Chinese | ||
| 37811784 | 贝达药业股份有限公司章程（草案）（2026年1月） | 2026-02-01 | Chinese | ||
| 37811776 | 贝达药业股份有限公司章程（草案）修订对照表 | 2026-02-01 | Chinese | ||
| 37811773 | 贝达药业股份有限公司内幕信息知情人登记管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811770 | 关于修订H股发行并上市后适用的《公司章程（草案）》及相关议事规则（草案）的公告 | 2026-02-01 | Chinese | ||
| 37811768 | 贝达药业股份有限公司子公司管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811761 | 贝达药业股份有限公司独立董事专门会议工作制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811758 | 贝达药业股份有限公司投资者关系管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811744 | 第五届董事会第一次会议决议公告 | 2026-02-01 | Chinese | ||
| 37811740 | 贝达药业股份有限公司股东会议事规则（草案）（2026年1月） | 2026-02-01 | Chinese | ||
| 37811736 | 贝达药业股份有限公司信息披露管理制度（2026年1月） | 2026-02-01 | Chinese | ||
| 37811733 | 贝达药业股份有限公司董事和高级管理人员离职管理制度（2026年1月） | 2026-02-01 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.